REQUEST A DEMO
Total
USD $0.00
Search more companies

The Medic Pharma Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: The Medic Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Medic Pharma Company Limited is based in Thailand. The head office is in Bangkok , Special Governed District of. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The Medic Pharma Company Limited was incorporated on May 14, 1971. From the latest financial highlights, The Medic Pharma Company Limited reported a net sales revenue increase of 9.92% in 2024. Its’ total assets recorded a growth of 9.93%. The enterprise’s net profit margin increased by 2.25% in 2024.

Headquarters
450 Soi Rama Ii Soi 50
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10150

Contact Details: Purchase the The Medic Pharma Company Limited report to view the information.

Basic Information
Financial Auditors:
Purchase the The Medic Pharma Company Limited report to view the information.
Incorporation Date:
May 14, 1971
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after The Medic Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
9.92%
Total Operating Revenue
10.11%
Operating Profit
31%
EBITDA
31%
Net Profit/Loss for the Period
29.09%
Total Assets
9.93%
Total Equity
10.83%
Operating Profit Margin
2.52%
Net Profit Margin
2.25%
Return on Equity (ROE)
1.67%
Quick Ratio
0.36%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?